Helminthiases in children: clinical picture, diagnosis, treatment and prevention

DOI: https://dx.doi.org/10.18565/pharmateca.2022.1.67-71

K.D. Ermolenko

Pediatric Research and Clinical Center for Infectious Diseases FMBA of Russia, St. Petersburg, Russia
Data on the prevalence of helminthiases in the world are pressented; the clinical picture, approaches to the diagnosis, treatment and prevention of helminthiases in children and adults are discussed. It is shown that a feature of helminthiases is considered to be a wide prevalence among the child population. The variety of symptoms of helminthiases indicates the complexity of diagnosing this group of diseases and the need to use a complex of clinical and laboratory-instrumental methods. After establishing a diagnosis, patients undergo anthelmintic therapy, including dietary treatment, the administration of etiotropic, pathogenetic and symptomatic agents. Specific treatment is the basis for the therapy of most human helminthiases. Among anthelmintic drugs, albendazole is one of the most effective in both tissue and luminal forms of helminthiases.

About the Autors

Corresponding author: Konstantin D. Ermolenko, Cand. Sci. (Med.), Researcher at the Pediatric Research and Clinical Center for Infectious Diseases of the FMBA of Russia, Research Department of Intestinal Infections, St. Petersburg, Russia; ermolenko.kd@yandex.ru; ORCID: https://orcid.org/0000-0002-1730-8576

Бионика Медиа